keyword
MENU ▼
Read by QxMD icon Read
search

Pkpd antibiotics

keyword
https://www.readbyqxmd.com/read/27578330/a-whole-body-physiologically-based-pharmacokinetic-wb-pbpk-model-of-ciprofloxacin-a-step-towards-predicting-bacterial-killing-at-sites-of-infection
#1
Muhammad W Sadiq, Elisabet I Nielsen, Dalia Khachman, Jean-Marie Conil, Bernard Georges, Georges Houin, Celine M Laffont, Mats O Karlsson, Lena E Friberg
The purpose of this study was to develop a whole-body physiologically based pharmacokinetic (WB-PBPK) model for ciprofloxacin for ICU patients, based on only plasma concentration data. In a next step, tissue and organ concentration time profiles in patients were predicted using the developed model. The WB-PBPK model was built using a non-linear mixed effects approach based on data from 102 adult intensive care unit patients. Tissue to plasma distribution coefficients (Kp) were available from the literature and used as informative priors...
August 30, 2016: Journal of Pharmacokinetics and Pharmacodynamics
https://www.readbyqxmd.com/read/26983860/a-pharmacokinetic-pharmacodynamic-pkpd-model-based-on-in-vitro-time-kill-data-predicts-the-in-vivo-pk-pd-index-of-colistin
#2
David D Khan, Lena E Friberg, Elisabet I Nielsen
OBJECTIVES: For antibiotics, extensive animal PKPD studies are often performed to evaluate the PK/PD driver for subsequent use when recommending dosing regimens. The aim of this work was to evaluate a PKPD model, developed based on in vitro time-kill data for colistin, in predicting the relationships between PK/PD indices and the bacterial killing previously observed in mice. METHODS: An in silico PKPD model for Pseudomonas aeruginosa exposed to colistin was previously developed based on static in vitro time-kill data...
July 2016: Journal of Antimicrobial Chemotherapy
https://www.readbyqxmd.com/read/26786016/simulation-based-evaluation-of-pk-pd-indices-for-meropenem-across-patient-groups-and-experimental-designs
#3
Anders N Kristoffersson, Pascale David-Pierson, Neil J Parrott, Olaf Kuhlmann, Thierry Lave, Lena E Friberg, Elisabet I Nielsen
PURPOSE: Antibiotic dose predictions based on PK/PD indices rely on that the index type and magnitude is insensitive to the pharmacokinetics (PK), the dosing regimen, and bacterial susceptibility. In this work we perform simulations to challenge these assumptions for meropenem and Pseudomonas aeruginosa. METHODS: A published murine dose fractionation study was replicated in silico. The sensitivity of the PK/PD index towards experimental design, drug susceptibility, uncertainty in MIC and different PK profiles was evaluated...
May 2016: Pharmaceutical Research
https://www.readbyqxmd.com/read/25365600/a-mathematical-model-for-antibiotic-control-of-bacteria-in-peritoneal-dialysis-associated-peritonitis
#4
Colette Calmelet, John Hotchkiss, Philip Crooke
A study of the process of pharmacokinetics-pharmacodynamics (PKPD) of antibiotics and their interaction with bacteria during peritoneal dialysis associated peritonitis (PDAP) is presented. We propose a mathematical model describing the evolution of bacteria population in the presence of antibiotics for different peritoneal dialysis regimens. Using the model along with experimental data, clinical parameters, and physiological values, we compute variations in PD fluid distributions, drug concentrations, and number of bacteria in peritoneal and extra-peritoneal cavities...
December 2014: Mathematical Biosciences and Engineering: MBE
https://www.readbyqxmd.com/read/23803529/pharmacokinetic-pharmacodynamic-modeling-of-antibacterial-drugs
#5
REVIEW
Elisabet I Nielsen, Lena E Friberg
Pharmacokinetic-pharmacodynamic (PKPD) modeling and simulation has evolved as an important tool for rational drug development and drug use, where developed models characterize both the typical trends in the data and quantify the variability in relationships between dose, concentration, and desired effects and side effects. In parallel, rapid emergence of antibiotic-resistant bacteria imposes new challenges on modern health care. Models that can characterize bacterial growth, bacterial killing by antibiotics and immune system, and selection of resistance can provide valuable information on the interactions between antibiotics, bacteria, and host...
July 2013: Pharmacological Reviews
https://www.readbyqxmd.com/read/21807983/pharmacokinetic-pharmacodynamic-pk-pd-indices-of-antibiotics-predicted-by-a-semimechanistic-pkpd-model-a-step-toward-model-based-dose-optimization
#6
Elisabet I Nielsen, Otto Cars, Lena E Friberg
A pharmacokinetic-pharmacodynamic (PKPD) model that characterizes the full time course of in vitro time-kill curve experiments of antibacterial drugs was here evaluated in its capacity to predict the previously determined PK/PD indices. Six drugs (benzylpenicillin, cefuroxime, erythromycin, gentamicin, moxifloxacin, and vancomycin), representing a broad selection of mechanisms of action and PK and PD characteristics, were investigated. For each drug, a dose fractionation study was simulated, using a wide range of total daily doses given as intermittent doses (dosing intervals of 4, 8, 12, or 24 h) or as a constant drug exposure...
October 2011: Antimicrobial Agents and Chemotherapy
https://www.readbyqxmd.com/read/21419854/pharmacokinetic-pharmacodynamic-modelling-of-the-effect-of-moxifloxacin-on-qtc-prolongation-in-telemetered-cynomolgus-monkeys
#7
Kenny J Watson, William P Gorczyca, John Umland, Ying Zhang, Xian Chen, Sunny Z Sun, Bernard Fermini, Mark Holbrook, Piet H Van Der Graaf
INTRODUCTION: Delayed ventricular repolarisation is manifested electrocardiographically in a prolongation of the QT interval. Such prolongation can lead to potentially fatal Torsades de Pointes. Moxifloxacin is a fluoroquinolone antibiotic which has been associated with QT prolongation and, as a result, is recommended by the regulatory authorities as a positive control in thorough QT studies performed to evaluate the potential of new chemical entities to induce QT prolongation in humans...
May 2011: Journal of Pharmacological and Toxicological Methods
https://www.readbyqxmd.com/read/21282424/predicting-in-vitro-antibacterial-efficacy-across-experimental-designs-with-a-semimechanistic-pharmacokinetic-pharmacodynamic-model
#8
Elisabet I Nielsen, Otto Cars, Lena E Friberg
We have previously described a general semimechanistic pharmacokinetic-pharmacodynamic (PKPD) model that successfully characterized the time course of antibacterial effects seen in bacterial cultures when exposed to static concentrations of five antibacterial agents of different classes. In this PKPD model, the total bacterial population was divided into two subpopulations, one growing drug-susceptible population and one resting drug-insensitive population. The drug effect was included as an increase in the killing rate of the drug-susceptible bacteria with a maximum-effect (E(max)) model...
April 2011: Antimicrobial Agents and Chemotherapy
1
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"